Leadless CRT Alternative Slated For U.S.-based Clinical Trial In 2017
New technology that can wirelessly resynchronize the chambers of the heart is making its way toward U.S.-based clinical trials in early 2017. EBR Systems’ WiSE technology is an endocardial pacing system for cardiac resynchronization therapy (CRT), designed to address flaws in conventional CRT systems that are ineffective in one-third of eligible heart failure (HF) patients.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news
More News: Cardiac Resynchronization Therapy | Cardiology | Clinical Trials | Heart | Heart Failure | Medical Devices